Patient & Visitor InformationContact Us
  • Supportive Care Protocols

  • Solid Tumors

    1. A Randomized, Blinded, Placebo-controlled, Two-Phase, Sequential Cohort, Dose Finding Study to Assess the Safety and Efficacy of an Oral Thrombopoietin Receptor Agonist, Eltrombopag (SB-497115-GR), Administered to Patients with Solid Tumors Receiving Gemcitabine monotherapy or the combination of Gemcitabine Plus Carboplatin or Cisplatin (TRC112765)
      PI: Eric Winer, MD
      Sites: Rhode Island Hospital, The Miriam Hospital
      Learn more about this study